WILLIAM SERA: Open Payments
NPI 1679747646 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,440 in 69 payments from 17 companies in 2025. Trend: 2023 $1,263 · 2024 $1,462 · 2025 $1,440
Food & beverage: $1,440
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $215 |
| Xeris Pharmaceuticals, Inc. | 12 | $173 |
| Radius Health, Inc. | 2 | $157 |
| Dexcom, Inc. | 8 | $142 |
| Lilly USA, LLC | 7 | $127 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $120 |
| Novo Nordisk Inc | 5 | $111 |
| Acella Pharmaceuticals, LLC | 5 | $89 |
| RECORDATI_RARE_DISEASES_INC. | 3 | $73 |
| Amgen Inc. | 4 | $71 |
Products named: Kerendia, Tymlos, JARDIANCE, RECORLEV, Dexcom G6 Transmitter, MOUNJARO, NP Thyroid 60, ISTURISA.
Industry payments across NM — which companies pay providers there.
